This study showed that a continuous subcutaneous infusion of PP increased insulin sensitivity and resulted in a reduction in daily insulin requirements in a varied group of T2DM and type 3c diabetes mellitus (T3cDM) patients on insulin pump therapy. Here, INS is linked to type 2 diabetes mellitus.